Entering text into the input field will update the search result below

More on China Nepstar Chain Drugstore's Q4

Mar. 29, 2016 6:15 AM ETChina Nepstar Chain Drugstore Ltd. (NPD) StockBy: Niloofer Shaikh, SA News Editor
  • China Nepstar Chain Drugstore (NYSE:NYSE:NPD) reports comparable-store sales rose 12.5% in Q4 primarily due to in-store promotional initiatives and improved average store output.
  • Revenue contribution by products: Prescription drugs 21.7%; OTC 46.9%; Nutritional supplements 9.3%; Herbal products 4.3%; Convenience and other products 17.8%.
  • Private label products sales represents ~12% of the total revenue & 16.3% of the gross profit.
  • Gross margin rate expanded 230 bps to 44.7%.
  • Inventory +5.1% Y/Y to RMB574.34M.
  • Store count +33 Q/Q to 1,998.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
NPD--
China Nepstar Chain Drugstore Ltd.